Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug's first entry ...

Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

Lured to Cambodia, tortured and forced to defraud strangers online, a Thai teenager said he barely survived after he threw ...

The launch in Thailand marks Wegovy’s entry into the Southeast Asian market. Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

As of May 22, manufacturers are no longer allowed to distribute the compounded versions of semaglutide, which Novo Nordisk sells under the brand Wegovy for weight loss and Ozempic for diabetes.

Wegovy is a prescription drug used for long-term weight management. Learn about the side effects it can cause and how to manage them.

Dec. 4, 2024 – People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial. Those who took Zepbound lost on ...

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

Wegovy (semaglutide) is a weight loss medicine. The FDA first approved Wegovy in 2021 to help people who are overweight or have obesity lose weight and keep it off. In 2024, Wegovy was also ...

BANGKOK (Reuters) -Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug ...